Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to acquire PaxVax, a company focused on specialty vaccines that protect against existing and emerging infectious diseases, for an all-cash consideration of $270 million. PaxVax is majority owned by an affiliate of Cerberus Capital Management, L.P.
Maryland’s health tech startup ecosystem is at it again. Silver Spring-based startup which is named as Aziyo Biologics Inc. has raised an amount of $10 million from seven leading investors in a funding round which has been disclosed yesterday night in SEC filings.
After a week of persistent rain throughout Maryland, it was blue skies and a perfect 85-degree summer afternoon that marked an important day for Paragon Bioservices and their 250+ employees. Dozens of those employees stepped off a charter bus from Baltimore to see the brand new 151,000 sq/ft GMP biomanufacturing facility near BWI for the first time. The wide-open parking lots and 200 yards between the nearest building presented a much different landscape than they were used to at their current UM BioPark location in the city. An afternoon picnic and site tour was organized as a celebration for their employees, who got to enjoy some delicious ole’ fashioned BBQ, music and games outside before a short welcome ceremony.
We want to offer you the best possible experience when using the OrganoPlate® for your experiments. This page contains training videos and protocols to get you started. For optimal user experience, we recommend you to follow these 5 steps before your first experiment:
Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces today two key leadership promotions. Deborah Wild has been promoted from Vice President, Quality, Validation and Regulatory Affairs to Senior Vice President, Quality, Validation and Regulatory Affairs, and Ruby Hofmann has been promoted from Vice President, Human Resources and Organizational Development to Senior Vice President, Human Resources, and Organizational Development.
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that the Eversense® CGM System is now available at trained clinics across the U.S. and physicians have begun sensor placements with patients. Concurrently, the company reported that its first commercial payer, Horizon Blue Cross Blue Shield of New Jersey and Horizon Healthcare of New Jersey, has added coverage of the Eversense System to its Medical Policy.
Johns Hopkins University has been awarded up to $30 million to lead a consortium of three Mid-Atlantic universities that will work together on research projects with the National Institute of Standards and Technology.
Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, announced that it has distributed to shareholders a mid-year update letter reviewing the company’s recent progress and clinical plans for the remainder of 2018 and 2019.
Meet RESI’s Network of Global Investors and Channel Partners
This fall, the Redefining Early Stage Investments Conference (RESI) will expand to include tech hubs and companies from the First Coast: DC, MD, PA, NJ, NY, RI, CT, and MA. RESI invites earliest stage companies from the discovery stage through venture stage: companies seeking grants, seed, angel, series A, and series B funding.
As a client/partner of BioHealth Innovation and/or an early stage biohealth start-up in the BioHealth Capital Region, you can attend the RESI Boston September Conference at a reduced rate – $300 each ticket for the first 5 signups; each ticket valued at $1,295.
RESI is a partnering vehicle for you to connect with global investors and strategic partners. You’ll have an opportunity to showcase your technology and assets in a poster board format with our table in the exhibit hall. You can participate in partnering and networking all day, and explore the exhibit hall, investor panels and entrepreneur workshops.
Email BioHealth Innovation for the Discount Code and Register Now
$300 for Tech Hub Members Includes:
